Coronavirus Notebook: ‘No Urgent Need’ For Booster Vaccines, But EU & UK Advise Additional Doses In Immunocompromised

 
• By Ian Schofield

ExeVir Bio has begun a Phase Ib study of its neutralizing antibody XVR011, NRx Pharmaceuticals has reported promising results with aviptadil in improving lung function, and Meletios Therapeutics has raised funds to further the development of an antiviral that acts on the SARS-CoV-2 virus and infected host cells.

Immunological system, antibodies attacking the virus covid-19.
Extra COVID-19 vaccine doses could be used for people with compromised immune systems • Source: Alamy

More from Europe

More from Geography